Home The effects of adrenocorticotrophic hormone and cortisol on homocysteine and vitamin B concentrations
Article
Licensed
Unlicensed Requires Authentication

The effects of adrenocorticotrophic hormone and cortisol on homocysteine and vitamin B concentrations

  • Anna L. Berg , Arnar T. Rafnsson , Magnus Johannsson , Björn Hultberg and Margret Arnadottir
Published/Copyright: September 21, 2011

Abstract

Background: Homocysteine metabolism is mainly governed by serum concentrations of folate and vitamin B12, renal function and genetic factors. It is also well documented that endocrinological disturbances influence homocysteine metabolism. However, studies on the hormones of the hypothalamic-pituitary-adrenal axis have given conflicting results.

Methods: A total of 30 healthy young males were randomised into three groups of equal size; one group received adrenocorticotrophic hormone (ACTH)1–24 1mg i.m. daily for 4days, another group was treated with cortisol 50mg i.m. t.i.d. for 4days, while a control group was observed for 4days. Fasting blood samples were collected before and after treatment or observation.

Results: The pattern of changes was the same for the ACTH and cortisol groups; there were significant decreases in serum concentrations of folate (23% and 24%) and cobalamines (13% and 19%) and decreases in plasma total homocysteine concentrations that did not reach significance. There were no changes in the control group.

Conclusions: The virtually identical pattern of changes in both treatment groups suggests that the effects were mediated by cortisol. The reductions in serum concentrations of folate and cobalamines call for further research.


Corresponding author: Margret Arnadottir, Division of Nephrology, Department of Medicine, Landspitali University Hospital Hringbraut, 101 Reykjavik, Iceland Phone: +354-5431000, Fax: +354-5436467,

References

1. Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB. Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol 2002; 31:59–70.10.1093/ije/31.1.59Search in Google Scholar

2. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. J Am Med Assoc 2002;288:2015–22.10.1001/jama.288.16.2015Search in Google Scholar

3. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338:1042–50.10.1056/NEJM199804093381507Search in Google Scholar

4. Nedrebo BG, Ericsson UB, Nygard O, Refsum H, Ueland PM, Aakvaag A, et al. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism 1998; 47:89–3.10.1016/S0026-0495(98)90198-6Search in Google Scholar

5. Smolders RG, van der Mooren MJ, Sipkema P, Kenemans P. Estrogens, homocysteine, vasodilation and menopause: basic mechanisms, interactions and clinical implications. Gynecol Endocrinol 2003; 17:339–54.Search in Google Scholar

6. Martinez-Taboada VM, Bartolome MJ, Fernandez-Gonzalez MD, Blanco R, Rodrigues-Valverde V, Lopesz-Hoyos M. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy. Rheumatology 2003; 42:1055–61.10.1093/rheumatology/keg293Search in Google Scholar

7. Terzolo M, Allasino B, Bosio S, Brusa E, Daffara F, Ventura M. Hyperhomocysteinemia in patients with Cushing's syndrome. J Clin Endocrinol Metab 2004; 89:3745–51.10.1210/jc.2004-0079Search in Google Scholar

8. Faggiano A, Melis D, Alfieri R, De Martino MC, Filippella M, Milone F, et al. Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease. J Clin Endocrinol Metab 2005; 90:6616–22.10.1210/jc.2005-0656Search in Google Scholar

9. Lazzerini PE, Capecchi PL, Bisogno S, Galeazzi M, Marcolongo R, Pasini FL. Reduction in plasma homocysteine levels in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. Ann Rheum Dis 2003; 62:694–5.10.1136/ard.62.7.694Search in Google Scholar

10. Kim MH, Kim E, Passen EL, Meyer J, Kang SS. Cortisol and estradiol: nongenetic factors for hyperhomocyst(e)inemia. Metabolism 1997; 46:247–9.10.1016/S0026-0495(97)90248-1Search in Google Scholar

11. Dierkes J, Westphal S, Luley C. The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels. Expert Opin Drug Saf 2004; 3:101–11.10.1517/14740338.3.2.101Search in Google Scholar

12. Berg AL, Nilsson-Ehle P. Direct effect on corticotropin plasma lipoprotein metabolism in man – studies in vivo and in vitro. Metabolism 1994; 43:90–7.10.1016/0026-0495(94)90162-7Search in Google Scholar

13. Rafnsson AT, Johannsson M, Olafsson I, Dallongeville J, Erfurth EM, Berg AL, et al. Effects of different doses of adrenocorticotrophic hormone on the serum lipoprotein profile in healthy subjects. Basic Clin Pharmacol Toxicol 2005; 97:86–90.10.1111/j.1742-7843.2005.pto_108.xSearch in Google Scholar

14. Andersson A, Isaksson A, Brattström L, Hultberg B. Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization. Clin Chem 1993; 39:1590–97.10.1093/clinchem/39.8.1590Search in Google Scholar

15. Refsum H, Guttormsen AB, Fiskerstrand T, Ueland PM. On the formation and fate of total plasma homocysteine. In: Graham I, Refsum H, Rosenberg IH, Ueland PM, editors. Homocysteine metabolism: from basic science to clinical medicine. Boston, MA: Kluwer Academic, 1997:23–30.Search in Google Scholar

16. Finkelstein JD, Kyle WE, Harris BJ. Methionine metabolism in mammals. Regulation of homocysteine methyltransferases in rat tissue. Arch Biochem Biophys 1971; 146:84–92.10.1016/S0003-9861(71)80044-9Search in Google Scholar

Received: 2006-1-2
Accepted: 2006-2-25
Published Online: 2011-9-21
Published in Print: 2006-5-1

©2006 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. CCLM: Expanding the science worldwide
  2. Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening
  3. Immunochemical quantification of free immunoglobulin light chains from an analytical perspective
  4. De novo deletion removes a conserved motif in the C-terminus of ABCA4 and results in cone-rod dystrophy
  5. Molecular detection of squamous cell carcinoma antigen transcripts in peripheral blood of cancer patients
  6. Influence of human haptoglobin polymorphism on oxidative stress induced by free hemoglobin on red blood cells
  7. Real-time RT-PCR quantification of PRAME gene expression for monitoring minimal residual disease in acute myeloblastic leukaemia
  8. Association of high-sensitive C-reactive protein with advanced stage β-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus
  9. A longitudinal evaluation of urinary glycosaminoglycan excretion in normoalbuminuric type 1 diabetic patients
  10. National survey on the execution of the oral glucose tolerance test (OGTT) in a representative cohort of Italian laboratories
  11. The reduction of cholesteryl linoleate in lipoproteins: an index of clinical severity in β-thalassemia/Hb E
  12. Alterations in serum glycosaminoglycan profiles in Graves' patients
  13. Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients
  14. Sandwich ELISAs for soluble immunoglobulin superfamily receptor translocation-associated 2 (IRTA2)/FcRH5 (CD307) proteins in human sera
  15. Utilizing ultrafiltration to remove alkaline phosphatase from clinical analyzer water
  16. Measurement of serum monoclonal components: comparison between densitometry and capillary zone electrophoresis
  17. Salivary aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase: possible markers in periodontal diseases?
  18. Reticulocyte count, mean reticulocyte volume, immature reticulocyte fraction, and mean sphered cell volume in elite athletes: reference values and comparison with the general population
  19. Serum homocysteine levels and paraoxonase 1 activity in preschool aged children in Greece
  20. The effects of adrenocorticotrophic hormone and cortisol on homocysteine and vitamin B concentrations
  21. Plasma, salivary and urinary cotinine in non-smoker Italian women exposed and unexposed to environmental tobacco smoking (SEASD study)
  22. Cut-off values for total serum immunoglobulin E between non-atopic and atopic children in north-west Croatia
  23. Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures
  24. Evaluation of serum levels of p53 in hepatocellular carcinoma in Egypt
  25. Insufficient filling of vacuum tubes as a cause of microhemolysis and elevated serum lactate dehydrogenase levels. Use of a data-mining technique in evaluation of questionable laboratory test results
  26. Evaluation of three different specimen types (serum, plasma lithium heparin and serum gel separator) for analysis of certain analytes: clinical significance of differences in results and efficiency in use
  27. Comparative evaluation of a new immunoradiometric assay for corticotropin
  28. Mast cells in atherosclerosis as a source of the cytokine RANKL
  29. Falsely increased total serum protein due to dextran interference
Downloaded on 7.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2006.114/html?lang=en
Scroll to top button